Affymetrix to Webcast Presentation at the 31st Annual JP Morgan Healthcare Conference

Updated

Affymetrix to Webcast Presentation at the 31st Annual JP Morgan Healthcare Conference

SANTA CLARA, Calif.--(BUSINESS WIRE)-- Affymetrix, Inc. (NAS: AFFX) today announced that it will webcast the Company's presentation at the 31st Annual JP Morgan Healthcare Conference in San Francisco, California on Thursday, January 10, 2013. The live webcast is scheduled to begin at 8:30 a.m. PT and will feature a corporate overview by Dr. Frank Witney, president and chief executive officer.


A live webcast will be available at http://www.affymetrix.com under the "Investors" link. The archived webcast will be available for 30 days.

About Affymetrix

Affymetrix technology is used by the world's top pharmaceutical, diagnostic, and biotechnology companies, as well as leading academic, government, and nonprofit research institutes. More than 2,200 systems have been shipped around the world and almost 26,000 peer-reviewed papers have been published using the technology. Affymetrix is headquartered in Santa Clara, California, and has manufacturing facilities in Cleveland, Ohio, and Singapore. eBioscience is headquartered in San Diego, California and has manufacturing facilities in San Diego and Vienna, Austria. Including eBioscience, the Company has about 1,100 employees worldwide and maintains sales and distribution operations across Europe, Asia and Latin America.

anImage
anImage



Affymetrix, Inc.
Doug Farrell, 408-731-5285
Vice President, Investor Relations

KEYWORDS: United States North America California

INDUSTRY KEYWORDS:

The article Affymetrix to Webcast Presentation at the 31st Annual JP Morgan Healthcare Conference originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Advertisement